Jodi Gureasko - Concepedia

Concepedia

Author

Jodi Gureasko

Howard Hughes Medical Institute

Also Known As

J. Gureasko, Jodi Gureasko, Jodi M. Gureasko

19

Publications

2.4K

Citations

8

H-Index

34

Concepts

All Affiliations

Howard Hughes Medical Institute Epizyme (United States)Lawrence Berkeley National Laboratory University of California, Berkeley New York University

JG

About

Jodi Gureasko is an author at Howard Hughes Medical Institute specializing in medicine, molecular biology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	2.1K
2	Biochemistry	4	4	474
3	Natural Sciences	3	3	222
4	Cell Biology	2	2	1.7K
5	Engineering	1	1	55

Jodi Gureasko

×

8

Publications

2.4K

Citations

8

H-Index

	Year	Citations
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor Xuewu Zhang, Jodi Gureasko, Kui Shen, Cell Kinase DomainDevelopmental BiologySignal TransductionSignaling PathwayReceptor Tyrosine Kinase	2006	1.6K
Membrane-dependent signal integration by the Ras activator Son of sevenless Jodi Gureasko, William J. Galush, Sean Boykevisch, Nature Structural & Molecular Biology Signal TransductionBiochemistryMembrane TransportSignal RecognitionIon Channels	2008	252
Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics Lars Iversen, Hsiung‐Lin Tu, Wan‐Chen Lin, Science Single Molecule BiophysicsSignal TransductionMolecular PhysiologyBiochemistryProtein Folding	2014	155
Calcium-independent stimulation of membrane fusion and SNAREpin formation by synaptotagmin I Lara K. Mahal, Sonia Sequeira, Jodi Gureasko, The Journal of Cell Biology	2002	109
Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless Jodi Gureasko, Olga Kuchment, Débora L. Makino, Proceedings of the National Academy of Sciences	2010	97
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation Michael J. Thomenius, Jennifer Totman, Darren M. Harvey, PLoS ONE Small Molecule InhibitorsEngineeringMolecular BiologySpecific Target MacromoleculesTumor Biology	2018	55
CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism Suzanne L. Jacques, Katrina P. Aquino, Jodi Gureasko, Biochemistry Molecular KineticsHuman EnzymeBiochemistryNatural SciencesCarm1 Activity	2016	44
Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IP Aravind Basavapathruni, Jodi Gureasko, Margaret Porter Scott, Biochemistry Cellular EnzymologyBiochemistryEnzymatic ActivityNatural SciencesSamdi Mass Spectrometry	2016	23

Page 1